Nervgen Pharma (NGEN) Retained Earnings (2024 - 2026)
Nervgen Pharma (NGEN) posted quarterly Retained Earnings of -$108.2 million for Q1 2026, down 2.85% quarter-over-quarter from -$105.2 million in Q4 2025.
Nervgen Pharma (NGEN) Retained Earnings (2024 - 2026) Analysis & Trends
Nervgen Pharma (NGEN) has reported Retained Earnings for 3 consecutive years, with -$108.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings changed N/A year-over-year to -$108.2 million; the TTM figure through Mar 2026 stood at -$108.2 million (changed N/A YoY), while the FY2025 annual figure was -$105.2 million, down 43.23% from the prior year.
- Retained Earnings retreated to -$108.2 million in Q1 2026 per NGEN's latest filing, from -$105.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$73.5 million in Q4 2024 and bottomed at -$108.2 million in Q1 2026.
- Historically, Retained Earnings has averaged -$95.7 million across 3 years, with a median of -$105.2 million in 2025.
- On a YoY basis, Retained Earnings climbed as much as 43.23% in 2025 and fell as far as 43.23% in 2025.
- Nervgen Pharma's Retained Earnings stood at -$73.5 million in 2024, then slumped by 43.23% to -$105.2 million in 2025, then slipped by 2.85% to -$108.2 million in 2026.
- Business Quant data shows NGEN's Retained Earnings at -$108.2 million in Q1 2026, -$105.2 million in Q4 2025, and -$73.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | Nervgen Pharma | 161.78 Mn | 161.78 Mn | - | -128.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.24 Mn |
| Dec 31, 2025 | -105.24 Mn |
| Dec 31, 2024 | -73.48 Mn |